Cargando…
Anti-Fibrotic Actions of Interleukin-10 against Hypertrophic Scarring by Activation of PI3K/AKT and STAT3 Signaling Pathways in Scar-Forming Fibroblasts
BACKGROUND: The hypertrophic scar (HS) is a serious fibrotic skin condition and a major clinical problem. Interleukin-10 (IL-10) has been identified as a prospective scar-improving compound based on preclinical trials. Our previous work showed that IL-10 has anti-fibrotic effects in transforming gro...
Autores principales: | Shi, Jihong, Li, Jun, Guan, Hao, Cai, Weixia, Bai, Xiaozhi, Fang, Xiaobing, Hu, Xiaolong, Wang, Yaojun, Wang, Hongtao, Zheng, Zhao, Su, Linlin, Hu, Dahai, Zhu, Xiongxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039501/ https://www.ncbi.nlm.nih.gov/pubmed/24878845 http://dx.doi.org/10.1371/journal.pone.0098228 |
Ejemplares similares
-
Autophagy protein LC3 regulates the fibrosis of hypertrophic scar by controlling Bcl-xL in dermal fibroblasts
por: Shi, Jihong, et al.
Publicado: (2017) -
Simultaneous deactivation of FAK and Src improves the pathology of hypertrophic scar
por: Su, Linlin, et al.
Publicado: (2016) -
IL‐10 alleviates lipopolysaccharide‐induced skin scarring via IL‐10R/STAT3 axis regulating TLR4/NF‐κB pathway in dermal fibroblasts
por: Shi, Jihong, et al.
Publicado: (2021) -
The Akt/FoxO/p27(Kip1) axis contributes to the anti‐proliferation of pentoxifylline in hypertrophic scars
por: Yang, Fangfang, et al.
Publicado: (2019) -
Disruption of the association between drug transporter and actin cytoskeleton abolishes drug resistance in hypertrophic scar
por: Su, Linlin, et al.
Publicado: (2016)